Navigation Links
Charles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of Directors
Date:9/18/2008

MADISON, Wis., Sept. 18 /PRNewswire/ -- Cellectar, Inc., a privately-held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced the appointment of Charles C. Harwood, Jr., to the Company's Board of Directors.

Mr. Harwood, 55, is a Healthcare Industry Advisor for Avista Capital Partners, a NYC-based private equity firm. Prior to working with Avista, Mr. Harwood was President and Chief Executive Officer of privately-held Focus Diagnostics, Inc. from 2002 until the company's sale in 2006. With more than 20 years of experience in the healthcare industry, he has also served as Senior Vice President and Chief Financial Officer of Covance, Inc., one of world's largest drug development service companies.

"Charlie brings exceptional financial and transaction expertise to the Cellectar Board," commented William Clarke, MD, M.Sc, President and CEO of Cellectar. "His years of experience in the drug development industry will prove beneficial to the Company as we advance our radiopharmaceutical products toward clinical testing and commercialization."

Mr. Harwood also serves on the Board of Directors at BioReliance, Inc., a contract research organization specializing in biological safety testing and specialized toxicology, RadPharm, Inc., a privately-held contract research organization located in Princeton, NJ, and Itero Biopharmaceuticals, Inc., a development stage company located in the San Francisco Bay Area.

About Cellectar

Cellectar, Inc. is a radiopharmaceutical company that designs, develops and manufactures products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs) analogs, with radioisotopes that can either image or destroy malignant cells. Cellectar's products' unique mechanism of action is based on their accumulation and selective retention in malignant tu
'/>"/>

SOURCE Cellectar, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology
2. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
3. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
4. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
5. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
6. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
7. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
8. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
9. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
10. GM Exec Joins Bio-Reaction Industries Board of Directors
11. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , AMSTERDA... the world,s,leading publisher of scientific, medi...ounced a major re-launch of Embase, its comprehens...n indexed records from more than 7,000,active, pee...ayed a key role in the advancement of new biomedic...
(Date:11/27/2009)..., , DURHAM, N.C., Nov. 27 /PRNewswi...ark, will initiate water-soluble carbon nanotube-b...ia. The water-soluble carbon nanotubes, which have...njugation with cancer drugs, was developed in part... The conjugated carbon nanotubes serves as a drug ...
(Date:11/26/2009)..., , WEST LAFAYETTE, Ind. - A new generation of ...chips using tiny structures called semiconducting ...ery by researchers at IBM, Purdue University and t...e researchers have learned how to create nanowires...ly defined at the atomic level, which is a critica...
(Date:11/25/2009)..., Ambassador to Speak at ... Toronto, Canada (Vocus) November 25, 2009 -- Amba..., ,Who: ,David Appia, French Ambassador for Intern...vest in France Agency ,To view a biography of Davi...: ,Ambassador Appia is available to meet with pres...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3French Ambassador for International Investment to Visit Toronto December 11 2
...ied for A1c testing using dried blood spot,specime...nternational LLC, a division of Hooper Holmes (Ame...emoglobin A1c testing methods by the National,Glyc...tage Labs uses two blood testing methods for hemog...nd the other for testing dried blood,spots (DBS), ...
...Nov. 11 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIG...esident and chief executive officer, will present ...hcare Conference on Thursday,November 13 at 4:30 p...a,Biltmore Resort in Phoenix, Arizona., To access... recording,log on to http://www.rigel.com . Pleas...
...hera Pharmaceuticals, Inc.,a privately held biopha...rugs, today announced new data on its lead product...ation (AHA) Annual Conference in New Orleans,Louis... varespladib for the,treatment of coronary heart d...laborators released new data from the Phase II PLA...
Other Biology Technology:Heritage Labs Announces A1c Test Certification Milestone 2Heritage Labs Announces A1c Test Certification Milestone 3Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease 2
(Date:11/30/2009)...Forsyth Institute, the University of Connecticut H...ve used state-of-the-art technology to elucidate t...he bacterium which causes syphilis. The previously...w be shown in three dimensions. This provides the ...ously unknown features, which may help fight the s...
(Date:11/30/2009)...rom LSU Health Sciences Center New Orleans School ...Institute of Child Health and Human Development (N...d Women,s Hospital, and Harvard Medical School, ha...n 5 servings of sugar- sweetened cola a week prior... risk of developing diabetes during pregnancy. Liw...
(Date:11/30/2009)... Global Conference on Systems & Enterprises (GCSE)..., focuses on the convergence of complex large-scal...o society. , The goal of the conference is t...rgeted complex systems, examined by domain, each s...al Infrastructure Systems, including Intelligent/S...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Alzheimers Drug Development Summit 3A CBI to Donate Portion of This Weeks Proceeds to the Alzheimers Association 14189 1Alzheimers Drug Development Summit 3A CBI to Donate Portion of This Weeks Proceeds to the Alzheimers Association 14189 2Alzheimers Drug Development Summit 3A CBI to Donate Portion of This Weeks Proceeds to the Alzheimers Association 14189 3Heritage Provider Network and Dr Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 57866 1Heritage Provider Network and Dr Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 57866 2Micell Receives 2415 Million Equity Investment 57861 1
...iversity have shown that common bacteria can deliv...a cell to precisely position sensors, drugs or DNA...diseases. , The approach represents a potential ... interiors of cells, where they could be used as a...hid Bashir, a researcher at Purdue,s Birck Nanotec...
...h brains untouched by a pathological process, howe... signs of dementia increases with the number of di...cording to a new study. The research was funded by...e National Institutes of Health, and conducted at ...sity Medical Center in Chicago. Julie Schneider, M...
...ered the most effective method yet to convert gluc...bundant sugar, to HFM, a chemical that can be brok...oleum. It has been an elusive goal for the legion...oil as the root source for plastic, fuels and scor...h inexpensive, nonpolluting renewable plant matter...
Other Biology News:Bacteria ferry nanoparticles into cells for early diagnosis, treatment 2Bacteria ferry nanoparticles into cells for early diagnosis, treatment 3Study finds mix of disease processes at work in brains of most people with dementia 2Plastic that grows on trees 2Plastic that grows on trees 3
Corning Resuable Pp Vial Rack, Non-Sterile, 50 Positions, Self Locking Design from Sigma-Aldrich
Corning Cryo Vial Rack, PC, Holds 30 Self-Standing Vials, Non-Sterile from Sigma-Aldrich
Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
... ChromQuest Chromatography Data System (CDS) now p...a acquisition, chromatography data processing and ...eed LC. The companys innovative HPLC instrument ha... Scientific Hypersil GOLD 1.9 m column particle te...
Biology Products: